$KSEZ
Kinetic Seas Inc.

2023 Q2 Form 10-Q Financial Statement

#000168316823003104 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $22.21K $2.726K $1.350K
YoY Change 220.65% 101.93%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $22.21K $2.726K $1.350K
YoY Change 220.65% 101.93%
Operating Profit -$22.21K -$2.726K -$1.350K
YoY Change 220.65% 101.93%
Interest Expense $8.490K $4.596K $2.248K
YoY Change 152.38% 104.45%
% of Operating Profit
Other Income/Expense, Net -$8.490K -$4.596K -$2.248K
YoY Change 152.38% 104.45%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$30.70K -$7.322K -$3.598K
YoY Change 198.33% 103.5% -25.01%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 $0.00 $0.00
Diluted Earnings Per Share -$0.01 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 140.8M shares 140.8M shares 140.8M shares
Diluted Shares Outstanding 3.046M shares 140.8M shares 140.8M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $5.112K $13.36K $24.66K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.112K $13.36K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.112K $13.36K
Total Long-Term Assets $0.00 $0.00
Total Assets $5.112K $13.36K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.03K $11.07K
YoY Change
Accrued Expenses $33.49K $33.49K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $199.3K $176.8K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $199.3K $176.8K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$994.9K -$964.2K
YoY Change
Common Stock $30.00 $1.408K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$194.2K -$163.5K -$65.62K
YoY Change
Total Liabilities & Shareholders Equity $5.112K $13.36K
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$30.70K -$7.322K -$3.598K
YoY Change 198.33% 103.5% -25.01%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$4.021K $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.00K $20.00K
YoY Change -20.0%
NET CHANGE
Cash From Operating Activities -$4.021K $0.00
Cash From Investing Activities $0.00
Cash From Financing Activities $16.00K $20.00K
Net Change In Cash $11.98K $20.00K
YoY Change -40.11%
FREE CASH FLOW
Cash From Operating Activities -$4.021K $0.00
Capital Expenditures $0.00
Free Cash Flow -$4.021K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash
Cash
1376 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
13355 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1376 usd
CY2023Q1 us-gaap Assets
Assets
13355 usd
CY2022Q4 us-gaap Assets
Assets
1376 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11071 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12366 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
26270 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
21674 usd
CY2023Q1 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
106000 usd
CY2022Q4 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
90000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001945619
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-56478
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
BELLATORA INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1981170
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2030 Powers Ferry Rd. SE
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite #212
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2023Q1 dei City Area Code
CityAreaCode
404
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
816-8240
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
140790867 shares
CY2023Q1 us-gaap Cash
Cash
13355 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
176827 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
157526 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140790867 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140790867 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140790867 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140790867 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1408 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1408 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
799278 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
799278 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-964157 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-956835 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-163471 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-156149 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13355 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1376 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2726 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1350 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2726 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1350 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2726 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1350 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
4596 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
2248 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4596 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2248 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7322 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3598 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140790867 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140790867 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140790867 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140790867 shares
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
140790867 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-62018 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3598 usd
CY2022Q1 us-gaap Shares Outstanding
SharesOutstanding
140790867 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-65616 usd
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
140790867 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-156149 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7322 usd
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
140790867 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-163471 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7322 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3598 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1295 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1350 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4596 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2248 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4021 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16000 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11979 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1376 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4663 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13355 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24663 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zLHQkvtxYAm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of accrued liabilities and expenses during the reporting period. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p>
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-964157 usd
CY2023Q1 ECGR Working Capital
WorkingCapital
-163471 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140790867 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140790867 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140790867 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140790867 shares

Files In Submission

Name View Source Status
0001683168-23-003104-index-headers.html Edgar Link pending
0001683168-23-003104-index.html Edgar Link pending
0001683168-23-003104.txt Edgar Link pending
0001683168-23-003104-xbrl.zip Edgar Link pending
bellatora_ex3101.htm Edgar Link pending
bellatora_ex3201.htm Edgar Link pending
bellatora_i10q-033123.htm Edgar Link pending
ecgr-20230331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
ecgr-20230331_cal.xml Edgar Link unprocessable
ecgr-20230331_def.xml Edgar Link unprocessable
ecgr-20230331_lab.xml Edgar Link unprocessable
ecgr-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bellatora_i10q-033123_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending